Image

Mississauga, Ontario Study Details

Study Reference No. - C2D03233

Study Type Demographic Gender Age Location Compensation
Healthy Healthy; not have smoked or used nicotine containing products (cigarettes, patches, gums, etc.) within 6 months before screening Males & Females 18-55 Mississauga, ON $2,150 to $2,530
Study Details

Study Purpose

The purpose of this study is to evaluate the safety and tolerability of the test product, CR9114. The study aims to develop CR9114 as a medication to prevent infection with influenza A and B.

Study Duration

Two period study; total duration of approximately 21 to 23 days depending on group assignment;

confinement varies depending on group assignment (note study visit schedule below).
Study Schedule

General Screening

N/A

Medical Screening

25, 30 September

Study Visit(s)
Group 1 & 2 Check in Dosing Check out Follow-up Phone Call Follow-up Visit
Period 1 19-Oct-23 20-Oct-23 20-Oct-23 01-Nov-23 08-Nov-23
Period 2 24-Oct-23 25-Oct-23 25-Oct-23
Group 3 & 4 Check in Dosing Check out Follow-up Phone Call Follow-up Visit
Period 1 22-Oct-23 23-Oct-23 24-Oct-23 06-Nov-23 13-Nov-23
Period 2 28-Oct-23 29-Oct-23 30-Oct-23
Other Notes

Bring Valid Photo ID.
I'm Interested!